85
Views
6
CrossRef citations to date
0
Altmetric
Short Report

Linagliptin use in older individuals with type 2 diabetes

Pages 1109-1114 | Published online: 16 Jul 2014

References

  • US Bureau of the Census65+ in the United StatesWashington, DCUS Government Printing Office1996
  • Centers for Disease Control and PreventionNational Diabetes Fact SheetNational Estimates and General Information on Diabetes and Prediabetes in the United StatesAtlanta, GACenters for Disease Control and Prevention2011
  • PleisJRWardBWLucasJWSummary health statistics for U.S. adults: National Health Interview Survey, 2009Vital Health Stat 102010249120721905346
  • KirkmanMSBriscoeVJClarkNDiabetes in older adultsDiabetes Care201235122650266423100048
  • LakeyWCBarnardKBatchBCChiswellKTasneemAGreenJBAre current clinical trials in diabetes addressing important issues in diabetes care?Diabetologia20135661226123523564296
  • American Diabetes AssociationStandards of medical care in diabetes – 2013Diabetes Care201336Suppl 1S11S6623264422
  • BodeBWBrettJFalahatiAPratleyREComparison of the efficacy and tolerability profile of liraglutide, a once-daily human GLP-1 analog, in patients with type 2 diabetes ≥65 and <65 years of age: a pooled analysis from phase III studiesAm J Geriatr Pharmacother20119642343322055210
  • GerminoFWNoninsulin treatment of type 2 diabetes mellitus in geriatric patients: a reviewClin Ther201133121868188222136979
  • MonamiMIacomelliIMarchionniNMannucciEDipeptydil peptidase-4 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trialsNutr Metab Cardiovasc Dis201020422423519515542
  • Januvia®(sitagliptin) tablets [prescribing information]Whitehouse Station, NJMerck & Co Inc2010
  • Nesina®(alogliptin) tablets [prescribing information]Deerfield, ILTakeda Pharmaceuticals America, Inc2013
  • Onglyza®(saxagliptin) tablets [prescribing information]Princeton, NJBristol-Myers Squibb Co2013
  • Galvus®(vildagliptin) tablets [prescribing information]BaselNovartis International AG2013
  • Tradjenta®(linagliptin) tablets [prescribing Information]IngelheimBoehringer-Ingelheim Int GmbH2013
  • PratleyRERosenstockJPi-SunyerFXManagement of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapyDiabetes Care200730123017302217878242
  • SchweizerADejagerSBosiEComparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trialDiabetes Obes Metab200911880481219476473
  • DoucetJChacraAMaheuxPLuJHarrisSRosenstockJEfficacy and safety of saxagliptin in older patients with type 2 diabetes mellitusCurr Med Res Opin201127486386921323504
  • KaryekarCSRavichandranSAllenEFlemingDFrederichRTolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥65 years) with inadequately controlled type 2 diabetes mellitusClin Interv Aging2013841943023626461
  • PratleyREMcCallTFleckPRWilsonCAMekkiQAlogliptin use in elderly people: a pooled analysis from phase 2 and 3 studiesJ Am Geriatr Soc200957112011201919793357
  • SchwartzSLTreatment of elderly patients with type 2 diabetes mellitus: a systematic review of the benefits and risks of dipeptidyl peptidase-4 inhibitorsAm J Geriatr Pharmacother20108540541821335294
  • StrainWDLukashevichVKothnyWHoellingerMJPaldániusPMIndividualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled studyLancet2013382989040941623706759
  • BarzilaiNGuoHMahoneyEMEfficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trialCurr Med Res Opin20112751049105821428727
  • RosenstockJWilsonCFleckPAlogliptin versus glipizide monotherapy in elderly type 2 diabetes mellitus patients with mild hyperglycaemia: a prospective, double-blind, randomized, 1-year studyDiabetes Obes Metab2013151090691423531118
  • BarnettAHHuismanHJonesRvon EynattenMPatelSWoerleHJLinagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trialLancet201338299021413142323948125
  • Sue KirkmanMBriscoeVJClarkNConsensus Development Conference on Diabetes and Older AdultsDiabetes in older adults: a consensus reportJ Am Geriatr Soc201260122342235623106132